Beta-lactam allergy de-labeling was safe and effective for older adult patients, successfully removing false allergy labels in 87.3% of cases, with no patients requiring hospitalization or ...

Pharma - Antibiotice Iași won the fifth tender organized by the UK National Health Service (NHS - the state healthcare system ...

These findings bolster existing clinical sentiment that once MSSA is confirmed, β-lactam agents, such as nafcillin or ...

Zaynich is based on cefepime, a well-established beta-lactam antibiotic, combined with a novel beta-lactamase inhibitor ...

Romanian pharmaceutical producer Antibiotice Iași (BVB: ATB) announced that it secured its fifth consecutive contract with the United Kingdom's National Health Service (NHS), significantly increasing ...

Drugmaker Wockhardt on Friday said that it has filed for regulatory approval of its Zaynich with the Drug Controller General ...

SCYNEXIS, Inc. (NASDAQ:SCYX) has officially restarted patient dosing in its Phase III MARIO trial for Brexafemme (ibrexafungerp) after the FDA lifted a nearly two-year clinical hold. The hold, ...

Wockhardt anticipates approval and launch of novel antibiotic Zaynich in India, US, and Europe, with significant market ...

Practices can delabel other suspected drug allergies while assessing patients for allergies to COVID-19 vaccines, according to a study published in Vaccine. This program can improve health-related ...

Romanian state-controlled drug maker Antibiotice [<a href=" target="_blank">BSE:ATB] said it has won a tender held by the ...

Highlighting the critical role played by President Bola Tinubu in creating an enabling environment for local manufacturing, ...